Biopharmaceutical Firm AstraZeneca Standardizes on DocuSign for DTM

June 15, 2015
The DocuSign Global Trust Network empowers biopharmaceutical companies like AstraZeneca to simplify clinical operations, decrease development costs, and reduce risk in security and compliance to bring treatments to market sooner and more efficiently. 14 of the top 15 global pharmaceutical companies and 9 of the top 10 Contract Research Organizations (CROs) have standardized on DocuSign for Digital Transaction Management (DTM).
Previous Video
Solgari Revolutionises the Telecommunications Industry with DocuSign
Solgari Revolutionises the Telecommunications Industry with DocuSign

Solgari have developed the technology, network and partnerships to deliver the world’s first complete enter...

Next Video
Effacts Partners with DocuSign to Help Legal Departments Go Digital
Effacts Partners with DocuSign to Help Legal Departments Go Digital

Effacts, the all in one legal management software company, partners with DocuSign to help legal departments...